Skip to main content
OpenTrials
Completed

NCT Number: NCT01998360

Rapid, Minimally-invasive Voluntary Adult Male Circumcision

This study will evaluate a new, minimally-invasive surgical circumcision technique for men, which is easy to learn and perform, is safe, and is associated with high patient satisfaction and excellent cosmetic results.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–99 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Simunye Primary Healthcare

Mitchells Plain, Western Cape, South Africa

About this study

Voluntary medical male circumcision (VMMC) is a priority preventive intervention for HIV transmission. Currently, the most widely used VMMC technique in South Africa is open surgical circumcision.

According to the Framework for Clinical Evaluation of Devices for Adult Male Circumcision (WHO, 2011): "WHO and other health authorities wish to identify one or more devices that (a) would make the VMMC safer, easier, and quicker; (b) would have more rapid healing than current methods and/or might entail less risk of HIV transmission in the post-operative period; (c) could be performed safely by health-care providers with a minimal level of training; and (d) would be cost-effective compared to standard surgical methods for male circumcision scale up."

This quasi-experimental compares the open surgical technique to an alternative minimally-invasive technique using the disposable Unicirc device with tissue adhesive. The controls come from a separate randomized controlled trial (Unicirc 001) that was conducted just prior to the Unicirc 002 case series of 50 subjects. The investigators postulate that VMMC using the Unicirc device meets WHO criteria for the ideal method to scale up: it is an easier technique to learn and perform, requires less intraoperative time, is safer for both surgeons and patients, heals quicker, and is more cost effective than other currently available techniques. The disposable nature of the device is an immense advantage as it eliminates the need to sterilize and can therefore be used in resource-limited settings. It also reduces the chances of infection caused by contaminated instruments.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Healthy men at least 18 years of age requesting circumcision

No anatomical penile abnormalities or infections

Able to provide informed consent to participate

Willing to participate in follow-up visits -

Exclusion criteria

Current illness

Penile abnormality or infection which contraindicates or would complicate circumcision

History of bleeding disorder

Past reaction to local anesthetic

-

Treatment and study plan

Surgical Control

Procedure

The study is quasi-experimental, because the open surgical controls are not contemporaneous. They were performed at the same center as part of Unicirc 001 trial with the same conditions as the subsequent 50 Unicirc circumcisions.

Unicirc with tissue adhesive

Procedure

Excision of foreskin with Unicirc device and wound sealing with tissue adhesive

Primary outcomes

  1. Intraoperative Duration

    Time frame: 1 hour

    The number of minutes required to perform the surgical procedure

Secondary outcomes

  1. Number of Participants With Adverse Events

    Time frame: 1 month

    Bleeding, hematoma, infection and other rare adverse events

  2. Blood Loss

    Time frame: During procedure (up to 1 hour)

    Number of ml of blood lost during the procedure, as assessed by the surgeon

  3. Number of Participants With Complete Epithelialization (Completely Healed) at 4 Weeks

    Time frame: 1 month

    The number of participants with complete epithelialization (completely healed) at 4 weeks

  4. Cosmetic Result

    Time frame: 6 weeks

    Regular: scar line straight without any irregularity

    Irregular: Some irregularity to scar line

    Scalloped: wavy appearane to scar line

Sponsors and collaborators

Lead sponsor

Simunye Primary Health Care

Other

Registry information

Official study title

Rapid, Minimally-invasive Voluntary Adult Male Circumcision: a Quasi-experimental Study

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Nov 28, 2013
Registry last updated
Oct 2, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.